Mounjaro (tirzepatide) is slightly different, combining the actions of GLP-1 and GIP receptors, potentially offering enhanced weight loss and glycemic control and some cardiovascular control
It contains the same active ingredient as the Wegovy injection (semaglutide) and works in the same way, by slowing gastric emptying and reducing appetite, so its side-effect profile is similar: mainly gastrointestinal effects such as nausea (the most common), vomiting, diarrhoea, and constipation, usually easing over time
The NUD cohort included 21,160 cases and 21,160 controls (n=42,320)
Thats the kind of data that moved the policy needle at Medicare
Due to the extensive monitoring required for diabetes, Ozempic is not feasible for telehealth services at Klinic